Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ACCELLERON IND. ADR/1 | ZH20 | Dec 23, 2024 | 47.00 | +1.29 |
Accent Resources NL | A2R | Dec 23, 2024 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Dec 23, 2024 | 0.03 | +10.64 |
Accentro Real Estate AG | A4Y | Dec 23, 2024 | 0.21 | -5.36 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Dec 23, 2024 | 345.65 | -1.61 |
Accesso Technology Group Plc | LQG | Dec 23, 2024 | 5.80 | -10.77 |
Acciona SA | AJ3 | Dec 23, 2024 | 108.40 | +1.40 |
Acco Brands Corporation | A3B | Dec 23, 2024 | 5.10 | -0.97 |
Accolade, Inc. | 4NE1 | Dec 23, 2024 | 3.30 | +4.43 |
Acconeer | 2LU | Dec 23, 2024 | 0.36 | +0.28 |
Accor | ACR1 | Dec 23, 2024 | 9.20 | +1.10 |
Accor SA | ACR | Dec 23, 2024 | 46.37 | +0.89 |
Accsys Technologies | 1D8 | Dec 23, 2024 | 0.52 | +2.75 |
Accuray Incorporated | XEJ | Dec 23, 2024 | 1.75 | -3.85 |
Ace Hardware Indonesia TBK | 4AH1 | Dec 23, 2024 | 0.04 | +2.53 |
ACE LIBERTY+STONE LS -,25 | 8MW | Dec 23, 2024 | 0.53 | 0.00 |
ACEA SpA | DCA | Dec 23, 2024 | 18.10 | +0.56 |
AcelRx Pharmaceuticals | R5XA | Dec 23, 2024 | 0.60 | +2.75 |
Acer Incorporated | AC5G | Dec 23, 2024 | 4.60 | 0.00 |
ACERINOX ADR 1/2/EO-,25 | ACE | Dec 23, 2024 | 4.50 | +3.69 |
Acerinox SA | ACE1 | Dec 23, 2024 | 9.35 | +1.19 |
Achieve Life Sciences, Inc. - | SP4P | Dec 23, 2024 | 3.48 | -3.34 |
Achilles Therapeutics plc - American Depositary Shares | 698 | Dec 23, 2024 | 0.91 | 0.00 |
ACI Worldwide, Inc. | TSA | Dec 23, 2024 | 50.50 | +1.00 |
ACINQUE S.P.A. EO 1 | YA2 | Dec 23, 2024 | 1.96 | +1.03 |
Ackermans & van Haaren NV | B3K | Dec 23, 2024 | 186.30 | +0.11 |
Aclara Resources Inc | JD1 | Dec 23, 2024 | 0.28 | +17.65 |
Aclaris Therapeutics, Inc. | 8AT | Dec 23, 2024 | 2.82 | +6.81 |
ACM Research, Inc. - Class A | 813 | Dec 23, 2024 | 14.13 | -1.15 |
Acma Ltd | AAX1 | Dec 23, 2024 | 0.01 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.